•
Jun 30, 2022

Akoya Q2 2022 Earnings Report

Akoya reported strong financial performance with record revenue and system placements.

Key Takeaways

Akoya Biosciences reported a 37% increase in revenue compared to the prior year period. The company sold 60 instruments, an increase of 94% from the prior year period. They are raising full year 2022 revenue guidance range to $71-74 million.

Total revenue was $17.9 million, an increase of 37% year-over-year.

Product revenue was $14.2 million, an increase of 33% year-over-year.

Services and other revenue totaled $3.7 million, an increase of 54% year-over-year.

60 instruments were sold, an increase of 94% year-over-year.

Total Revenue
$17.9M
Previous year: $13.1M
+36.9%
EPS
-$0.47
Previous year: -$0.2
+135.0%
Gross Profit
$10.3M
Previous year: $8.13M
+27.1%
Cash and Equivalents
$46.9M
Previous year: $135M
-65.4%
Free Cash Flow
-$15M
Previous year: -$13.4M
+11.9%
Total Assets
$184M
Previous year: $206M
-10.7%

Akoya

Akoya

Akoya Revenue by Segment

Forward Guidance

The company is raising its full year 2022 revenue guidance range to $71-74 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income